Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07923760
PHASE2

Supplemental Oxygen for Sleep-Disordered Breathing in Adults With Chronic Opioid Use.

Sponsor: University of California, San Diego

View on ClinicalTrials.gov

Summary

This study will evaluate whether supplemental oxygen given during sleep improves breathing stability and sleep-disordered breathing in adults who use prescription opioids long term. Participants will receive both supplemental oxygen and sham air during separate overnight sleep studies in a randomized order. The two study conditions will be separated by a washout period of approximately one week. Researchers will compare breathing during sleep with supplemental oxygen versus sham air and will also evaluate measures of oxygen levels, carbon dioxide levels, sleep quality, alertness, and other aspects of breathing and sleep. For participants who previously took part in the GENESIS study, qualifying assessments from that study may be used to meet certain baseline requirements when appropriate, which may reduce the need to repeat some testing.

Official title: Opioid Physiology and Individual Outcomes With Supplemental O₂ (OPIO2)

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

62

Start Date

2026-12-01

Completion Date

2031-12-01

Last Updated

2026-11-20

Healthy Volunteers

No

Interventions

OTHER

Sham Air

Sham air will be delivered during sleep through a nasal cannula using a standard wall air flow controller during an in-laboratory overnight polysomnography (PSG). Sham air will be delivered at a fixed flow rate of 4 L/min and may be reduced to 3 L/min for participant comfort.

DRUG

Supplemental Oxygen

Supplemental oxygen will be delivered during sleep through a nasal cannula using a standard wall oxygen flow controller during an in-laboratory overnight polysomnography (PSG). Supplemental oxygen will be delivered at a fixed flow rate of 4 L/min and may be reduced to 3 L/min for participant comfort.

Locations (1)

Altman Clinical and Translational Research Institute

La Jolla, California, United States